ISCHAEMIC SYMPTOMS, QUALITY OF CARE AND MORTALITY DURING MYOCARDIAL INFARCTION

Schelbert EB, Rumsfeld JS, Krumholz HM, Canto JG, Magid DJ, Masoudi FA, Reid KJ, Spertus JA

This study of 2094 consecutive myocardial infarction patients found that those in whom the admission symptoms were not documented in the patients’ records were less likely to receive aspirin or β-blockers within 24 hr, reperfusion therapy for STEMI or to survive their hospitalisation, and were also less likely to be discharged with aspirin, β-blockers, ACE/ARB or smoking cessation …